Table 2.
Relationship between clinical outcome and status of cag E, bab A2, bab B, ice A1, ice A2, and Cag A.
| Genotypes | Number (%) of isolates | Total (n = 109) | P value | ||
|---|---|---|---|---|---|
| NUD (n = 81) | PUD (n = 19) | GC (n = 9) | |||
| cag E | 40 (49.4%) | 13 (68.4%) | 8 (88.9%) | 61 (55.9%) | 0.198 |
| bab A2 | 60 (74%) | 16 (84.2%) | 0 | 76 (71.7%) | 0.001 |
| bab B | 53 (65.4%) | 12 (63.1%) | 0 | 65 (61.3%) | 0.005 |
| ice A1 | 29 (35.8%) | 8 (42.1%) | 9 (100%) | 46 (42.2%) | 0.008 |
| ice A2 | 11 (13.6%) | 3 (15.8%) | 0 | 14 (13.2%) | 0.779 |
| cag A | 53 (65.4%) | 15 (78.9%) | 9 (100%) | 77 (70.6%) | 0.134 |
NUD: nonulcer dyspepsia; PUD: peptic ulcer disease; GC: gastric cancer; Pv: P value.